Effects of dietary patterns and low protein intake on sarcopenia risk in the very old: The Newcastle 85+ study.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
01 2020
Historique:
received: 01 08 2018
revised: 10 12 2018
accepted: 10 01 2019
pubmed: 3 2 2019
medline: 4 5 2021
entrez: 3 2 2019
Statut: ppublish

Résumé

Sarcopenia, a progressive age-related loss of skeletal muscle mass and strength, leads to disability, falls, and hospitalisation. Individual variation in sarcopenia onset may be partly explained by lifestyle factors such as physical activity and diet. Healthy dietary patterns (DPs) have been linked to better physical functioning in older adults, but their role in sarcopenia in the very old (aged ≥85) is unknown. To investigate the association between DPs and the risk of sarcopenia over 3 years, and to determine whether protein intake influences this relationship in community-dwelling older adults from the Newcastle 85 + Study. The analytic sample consisted of 757 participants (61.2% women) who had dietary assessment at baseline. After two-step clustering with 30 food groups to derive DPs, we used logistic regression to determine the risk of prevalent and incident sarcopenia across DPs in all participants, and in those with low (<1 g/kg adjusted body weight/day [g/kg aBW/d]) and good protein intake (≥1 g/kg aBW/d). We identified three DPs (DP1: 'Low Red Meat', DP2: 'Traditional British' and DP3: 'Low Butter') that varied by unsaturated fat spreads/oils, butter, red meat, gravy and potato consumption. Compared with participants in DP3, those in DP2 had an increased risk of prevalent (OR = 2.42, 95% CI: 1.15-5.09, p = 0.02) but not 3-year incident sarcopenia (OR = 1.67, 0.59-4.67, p = 0.33) adjusted for socio-demographic, anthropometry, health and lifestyle factors. Furthermore, DP2 was associated with an increased risk of prevalent sarcopenia at baseline (OR = 2.14, 1.01-4.53, p = 0.05) and 3-year follow-up (OR = 5.45, 1.81-16.39, p = 0.003) after adjustment for key covariates in participants with good protein intake. A DP high in foods characteristic of a traditional British diet (butter, red meat, gravy and potato) was associated with an increased risk of sarcopenia even when overall protein intake was good. The results need to be replicated in other cohorts of the very old to understand the role of DPs in sarcopenia onset and management.

Sections du résumé

BACKGROUND
Sarcopenia, a progressive age-related loss of skeletal muscle mass and strength, leads to disability, falls, and hospitalisation. Individual variation in sarcopenia onset may be partly explained by lifestyle factors such as physical activity and diet. Healthy dietary patterns (DPs) have been linked to better physical functioning in older adults, but their role in sarcopenia in the very old (aged ≥85) is unknown.
AIMS
To investigate the association between DPs and the risk of sarcopenia over 3 years, and to determine whether protein intake influences this relationship in community-dwelling older adults from the Newcastle 85 + Study.
METHODS
The analytic sample consisted of 757 participants (61.2% women) who had dietary assessment at baseline. After two-step clustering with 30 food groups to derive DPs, we used logistic regression to determine the risk of prevalent and incident sarcopenia across DPs in all participants, and in those with low (<1 g/kg adjusted body weight/day [g/kg aBW/d]) and good protein intake (≥1 g/kg aBW/d).
RESULTS
We identified three DPs (DP1: 'Low Red Meat', DP2: 'Traditional British' and DP3: 'Low Butter') that varied by unsaturated fat spreads/oils, butter, red meat, gravy and potato consumption. Compared with participants in DP3, those in DP2 had an increased risk of prevalent (OR = 2.42, 95% CI: 1.15-5.09, p = 0.02) but not 3-year incident sarcopenia (OR = 1.67, 0.59-4.67, p = 0.33) adjusted for socio-demographic, anthropometry, health and lifestyle factors. Furthermore, DP2 was associated with an increased risk of prevalent sarcopenia at baseline (OR = 2.14, 1.01-4.53, p = 0.05) and 3-year follow-up (OR = 5.45, 1.81-16.39, p = 0.003) after adjustment for key covariates in participants with good protein intake.
CONCLUSION
A DP high in foods characteristic of a traditional British diet (butter, red meat, gravy and potato) was associated with an increased risk of sarcopenia even when overall protein intake was good. The results need to be replicated in other cohorts of the very old to understand the role of DPs in sarcopenia onset and management.

Identifiants

pubmed: 30709690
pii: S0261-5614(19)30011-1
doi: 10.1016/j.clnu.2019.01.009
pmc: PMC6961212
pii:
doi:

Substances chimiques

Dietary Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-173

Subventions

Organisme : Medical Research Council
ID : G0500997
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J50001X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601333
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Proc Nutr Soc. 2012 Nov;71(4):566-75
pubmed: 22429879
Am J Clin Nutr. 2015 Jul;102(1):115-22
pubmed: 25994567
Nutrition. 2015 Jan;31(1):97-104
pubmed: 25441592
Eur J Clin Nutr. 2009 Feb;63 Suppl 1:S6-18
pubmed: 19190647
Clin Nutr. 2014 Dec;33(6):929-36
pubmed: 24814383
Adv Nutr. 2015 May 15;6(3):293S-301S
pubmed: 25979502
J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1532-1537
pubmed: 29040508
PLoS One. 2015 Oct 21;10(10):e0139713
pubmed: 26488497
Eur J Nutr. 2018 Jun;57(4):1435-1448
pubmed: 28303397
Diabetes Metab. 2005 Dec;31 Spec No 2:5S20-5S26
pubmed: 16415762
Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):25-31
pubmed: 24310054
BMJ. 2009 Dec 22;339:b4904
pubmed: 20028777
Age Ageing. 2014 Nov;43(6):748-59
pubmed: 25241753
J Nutr Biochem. 2010 Jan;21(1):1-13
pubmed: 19800212
J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1059-64
pubmed: 17077199
Am J Clin Nutr. 2011 Feb;93(2):402-12
pubmed: 21159787
J Am Geriatr Soc. 2008 Jan;56(1):84-90
pubmed: 18005355
J Acad Nutr Diet. 2013 Jun;113(6):809-15
pubmed: 23491327
Clin Nutr. 2018 Dec;37(6 Pt A):2260-2270
pubmed: 29191494
Maturitas. 2012 Nov;73(3):197-201
pubmed: 22902240
Br J Nutr. 2015 Nov 14;114(9):1341-59
pubmed: 26344504
Curr Opin Clin Nutr Metab Care. 2012 Jan;15(1):12-22
pubmed: 22108098
J Nutr Health Aging. 2018;22(6):655-663
pubmed: 29806854
Diabetes Care. 2005 Oct;28(10):2541-2
pubmed: 16186295
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
Age Ageing. 2011 Mar;40(2):181-6
pubmed: 21239409
Eur J Phys Rehabil Med. 2013 Feb;49(1):131-43
pubmed: 23575207
J Am Med Dir Assoc. 2013 Dec;14(12):911-5
pubmed: 24094646
J Gerontol A Biol Sci Med Sci. 2017 Dec 12;73(1):88-94
pubmed: 28549098
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):229-237
pubmed: 27897431
J Hum Nutr Diet. 2015 Dec;28(6):636-45
pubmed: 25280068
Exp Gerontol. 2011 Apr;46(4):303-8
pubmed: 21111801
J Clin Endocrinol Metab. 2011 Oct;96(10):3250-6
pubmed: 21832109
J Nutr Health Aging. 2017;21(9):994-1001
pubmed: 29083440
Nutrients. 2016 May 14;8(5):
pubmed: 27187465
Acta Physiol (Oxf). 2010 Aug;199(4):509-18
pubmed: 20353493
J Gerontol A Biol Sci Med Sci. 2010 Feb;65(2):119-28
pubmed: 19959566
Clin Geriatr Med. 2011 Aug;27(3):401-21
pubmed: 21824555
J Am Med Dir Assoc. 2016 Apr 1;17(4):336-42
pubmed: 26774365
Clin Med (Lond). 2015 Dec;15 Suppl 6:s88-91
pubmed: 26634689
BMC Geriatr. 2007 Jun 26;7:14
pubmed: 17594470
Arch Gerontol Geriatr. 2014 Jan-Feb;58(1):74-9
pubmed: 24007938
J Frailty Aging. 2013;2(1):38-53
pubmed: 26082911
Maturitas. 2017 Sep;103:16-22
pubmed: 28778327
Eur J Clin Nutr. 2014 Sep;68(9):1001-7
pubmed: 24961545
J Am Geriatr Soc. 2012 Oct;60(10):1881-8
pubmed: 23035758
Clin Rheumatol. 2015 Oct;34(10):1673-80
pubmed: 25912213
J Am Med Dir Assoc. 2013 Aug;14(8):585-92
pubmed: 23537893
FASEB J. 2005 Mar;19(3):422-4
pubmed: 15596483
PLoS One. 2016 Mar 02;11(3):e0149699
pubmed: 26934360
Eur J Nutr. 2018 Dec;57(8):2713-2722
pubmed: 28948346
Clin Nutr. 2012 Oct;31(5):652-8
pubmed: 22414775
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):248-53
pubmed: 25807346
Age Ageing. 2015 Jan;44(1):96-102
pubmed: 24646604
Br J Nutr. 2016 Jun;115(12):2170-80
pubmed: 27087119
Am J Clin Nutr. 2002 Dec;76(6):1222-9
pubmed: 12450886
Appl Physiol Nutr Metab. 2010 Apr;35(2):199-206
pubmed: 20383233
J Appl Physiol (1985). 2000 Aug;89(2):465-71
pubmed: 10926627
J Am Geriatr Soc. 2019 Jan;67(1):50-56
pubmed: 30382594
Proc Nutr Soc. 2016 May;75(2):174-80
pubmed: 26620911
Br J Nutr. 2016 Aug;116(4):751-61
pubmed: 27363567
Age Ageing. 2013 Nov;42(6):727-34
pubmed: 24014657
Age Ageing. 2015 Jul;44(4):691-4
pubmed: 26018999
Proc Nutr Soc. 2016 Aug;75(3):420-30
pubmed: 27165559
Clin Interv Aging. 2015 May 11;10:859-69
pubmed: 25999704

Auteurs

Antoneta Granic (A)

AGE Research Group, Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, United Kingdom; NIHR Newcastle Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle Upon Tyne, United Kingdom; Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom. Electronic address: antoneta.granic@newcastle.ac.uk.

Nuno Mendonça (N)

Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom; Institute of Health & Society, Newcastle University, Newcastle Upon Tyne, United Kingdom; Human Nutrition Research Centre, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Avan A Sayer (AA)

AGE Research Group, Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, United Kingdom; NIHR Newcastle Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle Upon Tyne, United Kingdom; Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom.

Tom R Hill (TR)

Human Nutrition Research Centre, Newcastle University, Newcastle Upon Tyne, United Kingdom; Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Karen Davies (K)

AGE Research Group, Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, United Kingdom; NIHR Newcastle Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle Upon Tyne, United Kingdom; Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom.

Mario Siervo (M)

Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom; Human Nutrition Research Centre, Newcastle University, Newcastle Upon Tyne, United Kingdom; Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.

John C Mathers (JC)

Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom; Human Nutrition Research Centre, Newcastle University, Newcastle Upon Tyne, United Kingdom; Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Carol Jagger (C)

Newcastle University Institute for Ageing, Newcastle Upon Tyne, United Kingdom; Institute of Health & Society, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH